about
Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection.Anti-HIV activity of medicinal herbs: usage and potential development.Antiviral therapy for human immunodeficiency virus infectionsFlavones inhibit breast cancer proliferation through the Akt/FOXO3a signaling pathway.Rutin : therapeutic potential and recent advances in drug delivery.A Review of the Antiviral Properties of Black Elder (Sambucus nigra L.) Products.Human breast adenocarcinoma cytotoxicity and modulation of 7,12-dimethylbenz[a]anthracene-induced mammary carcinoma in Balb/c mice by Acacia catechu (L.f.) Wild heartwood.HIV type-1 entry inhibitors with a new mode of action.Reproductive and Developmental Toxicity of Orally Administered Botanical Composition, UP446-Part I: Effects on Embryo-Fetal Development in New Zealand White Rabbits and Sprague Dawley Rats.Topical anti-inflammatory activity of Thymus willdenowii.Randomized study of the efficacy and safety of oral elderberry extract in the treatment of influenza A and B virus infections.Reproductive and Developmental Toxicity of Orally Administered Botanical Composition, UP446-Part II: Effects on Prenatal and Postnatal Development, Including Maternal Function in Sprague-Dawley Rats.Anti-HIV activity of dibenzylbutyrolactone-type lignans from Phenax species endemic in Costa Rica.Ethnopharmacology of the Popoluca, Mexico: an evaluation.Reproductive and Developmental Toxicity of Orally Administered Botanical Composition, UP446-Part III: Effects on Fertility and Early Embryonic Development to Implantation in Sprague Dawley Rats.Medicinal Plants Used in the Treatment of Human Immunodeficiency Virus.Antiviral Activity of Compounds Isolated From Plants
P2860
Q33996826-5BB6319F-AA70-4B62-A800-A5FB1B9C68AEQ34231016-1E304A1A-65FF-4071-A5B5-C7FB73B1945AQ35366050-704C1EA2-8E00-441E-8E22-A825C3C0FA35Q35870864-FDE8929F-AD31-4991-BA22-68AEB7228DDAQ38116537-02334732-1076-4C18-9786-D868E718BB67Q39136167-B0256F53-9B20-4F93-89FD-58F49F6BBB91Q39246600-3C87779F-74F3-4C63-8AD8-7EE242D0191BQ39819133-5983CEDF-5957-474B-94EC-C473F95FD626Q40612101-1F83FB40-AAED-48E1-9402-A56AFD8E3A94Q43862258-38A80A39-2A46-4F4E-8FB2-7BFD9508E2C6Q45652929-9E6C7DA8-9364-4FC0-86E7-2A03935AC810Q46312376-4F2283E0-DAFF-4D7C-B19A-ABDC6BEE174DQ46654394-065159AD-AD42-4B4C-AE6E-0EE7F75EE100Q47588358-BDC1AB58-5D7C-4588-A49E-4A6C88E19A3BQ50577892-25D6C7AA-EED5-4FF9-B8D3-50B31B927DFFQ54212657-FC99B816-D33E-4748-BF50-1A0CA96759DAQ54297925-C31A3EDC-AC53-4448-8D12-F1D872B38052
P2860
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Inhibition of HIV infection by flavanoids.
@en
Inhibition of HIV infection by flavanoids.
@nl
type
label
Inhibition of HIV infection by flavanoids.
@en
Inhibition of HIV infection by flavanoids.
@nl
prefLabel
Inhibition of HIV infection by flavanoids.
@en
Inhibition of HIV infection by flavanoids.
@nl
P2093
P1433
P1476
Inhibition of HIV infection by flavanoids
@en
P2093
N De Tommasi
S Piacente
P304
P356
10.1016/0166-3542(93)90095-Z
P577
1993-10-01T00:00:00Z